Staar Surgical Co (STAA)
42.51
-0.29
(-0.68%)
USD |
NASDAQ |
May 21, 16:00
42.49
-0.02
(-0.05%)
After-Hours: 20:00
Staar Surgical Cash from Financing (Quarterly): 4.056M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.056M |
| December 31, 2023 | 0.367M |
| September 30, 2023 | 7.107M |
| June 30, 2023 | 1.302M |
| March 31, 2023 | -1.361M |
| December 31, 2022 | 0.202M |
| September 30, 2022 | 4.994M |
| June 30, 2022 | 2.207M |
| March 31, 2022 | 0.894M |
| December 31, 2021 | -0.216M |
| September 30, 2021 | 4.176M |
| June 30, 2021 | 7.833M |
| March 31, 2021 | 6.00M |
| December 31, 2020 | 6.55M |
| September 30, 2020 | 4.317M |
| June 30, 2020 | 7.44M |
| March 31, 2020 | 1.264M |
| December 31, 2019 | 0.828M |
| September 30, 2019 | -0.111M |
| June 30, 2019 | -0.328M |
| March 31, 2019 | -0.24M |
| December 31, 2018 | -0.446M |
| September 30, 2018 | 73.56M |
| June 30, 2018 | 1.452M |
| March 31, 2018 | 0.074M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.379M |
| September 30, 2017 | -0.01M |
| June 30, 2017 | 0.989M |
| March 31, 2017 | 0.079M |
| December 31, 2016 | 1.06M |
| September 30, 2016 | 0.797M |
| June 30, 2016 | 1.792M |
| March 31, 2016 | -0.696M |
| December 31, 2015 | -0.064M |
| September 30, 2015 | 0.157M |
| June 30, 2015 | 4.18M |
| March 31, 2015 | 0.306M |
| December 31, 2014 | 2.158M |
| September 30, 2014 | 0.04M |
| June 30, 2014 | 0.239M |
| March 31, 2014 | 2.142M |
| December 31, 2013 | 0.397M |
| September 30, 2013 | 1.574M |
| June 30, 2013 | 0.693M |
| March 31, 2013 | -0.219M |
| December 31, 2012 | 3.80M |
| September 30, 2012 | -0.029M |
| June 30, 2012 | -0.13M |
| March 31, 2012 | 0.642M |
| December 31, 2011 | 0.197M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.361M
Minimum
Mar 2023
7.833M
Maximum
Jun 2021
2.876M
Average
1.754M
Median
Cash from Financing (Quarterly) Benchmarks
| Anika Therapeutics Inc | -2.273M |
| The Cooper Companies Inc | 212.30M |
| OrthoPediatrics Corp | -0.573M |
| NexGel Inc | 0.929M |
| Innovative Eyewear Inc | -0.076M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 21.68M |
| Cash from Investing (Quarterly) | 16.19M |
| Free Cash Flow | 20.88M |
| Free Cash Flow Per Share (Quarterly) | 0.3369 |
| Free Cash Flow to Equity (Quarterly) | 16.48M |
| Free Cash Flow to Firm (Quarterly) | 16.48M |
| Free Cash Flow Yield | 1.00% |